Gene · 688
Papers3,365
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,365
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BCG vaccination impacts the epigenetic landscape of progenitor cells in human bone marrow. | bioRxiv | 2023 | 38077046 | PubTator, text mining | PubMed |
| Human Papillomavirus Infection in Penile Cancer: Multidimensional Mechanisms and Vaccine Strategies. | Int J Mol Sci | 2023 | 38069131 | PubTator, text mining | PubMed |
| Krüppel-like Factor-9 and Krüppel-like Factor-13: Highly Related, Multi-Functional, Transcriptional Repressors and Activators of Oncogenesis. | Cancers (Basel) | 2023 | 38067370 | PubTator, text mining | PubMed |
| Comprehensive Profiling and Therapeutic Insights into Differentially Expressed Genes in Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 38067357 | PubTator, text mining | PubMed |
| Identification and subtype analysis of biomarkers associated with the solute carrier family in acute myocardial infarction. | Medicine (Baltimore) | 2023 | 38065877 | PubTator, text mining | PubMed |
| The PENGUIN approach to reconstruct protein interactions at enhancer-promoter regions and its application to prostate cancer. | Nat Commun | 2023 | 38057321 | PubTator, text mining | PubMed |
| Prostate cancer genetic risk and associated aggressive disease in men of African ancestry. | Nat Commun | 2023 | 38052806 | PubTator, text mining | PubMed |
| Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy. | Acta Pharm Sin B | 2023 | 38045051 | PubTator, text mining | PubMed |
| hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancreatic ductal adenocarcinoma. | Mol Cancer | 2023 | 38044421 | PubTator, text mining | PubMed |
| Diagnostic model based on key autophagy-related genes in intervertebral disc degeneration. | BMC Musculoskelet Disord | 2023 | 38041088 | PubTator, text mining | PubMed |
| Upregulated PARP1 confers breast cancer resistance to CDK4/6 inhibitors via YB-1 phosphorylation. | Exp Hematol Oncol | 2023 | 38037159 | PubTator, text mining | PubMed |
| Extracellular vesicles in venous thromboembolism and pulmonary hypertension. | J Nanobiotechnology | 2023 | 38037042 | PubTator, text mining | PubMed |
| DNA methylation and histone post-translational modifications in atherosclerosis and a novel perspective for epigenetic therapy. | Cell Commun Signal | 2023 | 38031118 | PubTator, text mining | PubMed |
| Light at the ENDothelium-role of Sox17 and Runx1 in endothelial dysfunction and pulmonary arterial hypertension. | Front Cardiovasc Med | 2023 | 38028440 | PubTator, text mining | PubMed |
| FBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies. | Front Pharmacol | 2023 | 38027013 | PubTator, text mining | PubMed |
| ERVK13-1/miR-873-5p/GNMT Axis Promotes Metastatic Potential in Human Bladder Cancer though Sarcosine Production. | Int J Mol Sci | 2023 | 38003554 | PubTator, text mining | PubMed |
| Krüppel-like Factor 5 Plays an Important Role in the Pathogenesis of Chronic Pancreatitis. | Cancers (Basel) | 2023 | 38001687 | PubTator, text mining | PubMed |
| Self-Renewal Inhibition in Breast Cancer Stem Cells: Moonlight Role of PEDF in Breast Cancer. | Cancers (Basel) | 2023 | 38001682 | PubTator, text mining | PubMed |
| Biological Roles and Pathogenic Mechanisms of LncRNA MIR4435-2HG in Cancer: A Comprehensive Review. | Curr Issues Mol Biol | 2023 | 37998733 | PubTator, text mining | PubMed |
| Simvastatin Attenuates Areca Nut Extract-Induced Subdermal Fibrosis in Mice by Targeting TGF-β Signaling Pathways. | Curr Issues Mol Biol | 2023 | 37998719 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/688/papers?page=18